Is Wegovy safe to take while trying to get pregnant?

The FDA label advises stopping semaglutide at least 2 months before a planned pregnancy because of its roughly one-week half-life. This is a label instruction, not personal medical advice; confirm timing with your clinician.

Can Wegovy be used for PCOS-related weight?

It is not FDA-approved for PCOS. The 2023 International PCOS Guideline lists anti-obesity medications as an adjunct option when weight management is a treatment goal, so any PCOS use is off-label and clinician-directed.

GLP-1 receptor agonist (semaglutide 2.4 mg)

Wegovy (Semaglutide) for Women: What to Know

Medically reviewed by Editorial Medical Review, MD, NAMS-CMP · Updated July 2026

Quick answer

Wegovy is the brand name for semaglutide 2.4 mg, a once-weekly GLP-1 injection FDA-approved for chronic weight management. For women, the key points are that the label advises stopping it before a planned pregnancy and it is not recommended while breastfeeding. Unlike tirzepatide, its label carries no oral-contraceptive warning.

How it works

Semaglutide mimics the gut hormone GLP-1, slowing stomach emptying and acting on appetite centers in the brain to reduce hunger and calorie intake. In the STEP 1 trial, adults on semaglutide 2.4 mg lost about 14.9% of body weight over 68 weeks, versus about 2.4% on placebo.

FDA status for weight: FDA-approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition.

Women-specific considerations

These are factual notes from FDA labels and published guidelines, not personal medical advice. Discuss your situation with a licensed clinician.

Pregnancy

The FDA label advises discontinuing semaglutide at least 2 months before a planned pregnancy because of its long half-life (about 1 week). It is not recommended during pregnancy. This is a label instruction, not personal advice.

Breastfeeding

There is no human data on semaglutide in breast milk, and the label does not recommend use while breastfeeding. Timing decisions should be made with your clinician.

Birth control

Unlike tirzepatide, the semaglutide label does not warn of reduced oral-contraceptive effectiveness. However, weight loss can restore ovulation, so reliable contraception still matters if pregnancy is not intended.

PCOS

Semaglutide is not FDA-approved for PCOS. The 2023 International PCOS Guideline recognizes anti-obesity medications as an adjunct where weight management is a goal, so any PCOS use is off-label and clinician-directed.

Perimenopause weight

Weight gain around perimenopause is common, but Wegovy is approved based on BMI, not menopausal status. No menopause-specific trials establish a different effect in midlife women.

Who it is for (eligibility)

The FDA label indicates Wegovy for adults with obesity (BMI 30 or higher) or overweight (BMI 27 or higher) plus a weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. A licensed clinician determines suitability.

Cost (cited)

NovoCare self-pay (cash)

$499/mo

NovoCare / Wegovy self-pay pricing ↗

Commercial insurance + savings offer

$0-$200/mo

Wegovy coverage and savings ↗

Retail list price

$1,349/mo

GoodRx — Wegovy price guide (list + discounted) ↗

See the full cost breakdown in our cost guide.

Providers we review that offer this

Editorial reviews only — not treatment recommendations. Prescribing decisions rest with a licensed clinician. For the full directory, see all GLP-1 for women providers.

Form Health — Board-certified obesity medicine physicians prescribing GLP-1s. Often insurance-covered — among the most affordable options when insurance applies.
Noom Med — Noom’s GLP-1 telehealth arm pairing semaglutide/tirzepatide prescribing with behavior-change coaching.
Calibrate (Insurance) — Calibrate’s insurance-billing arm for women whose employer plan covers Wegovy or Zepbound.
Plushcare GLP-1 — Primary care telehealth that prescribes Wegovy and Zepbound when clinically appropriate. Insurance-friendly.

Frequently asked questions

Is Wegovy safe to take while trying to get pregnant?: The FDA label advises stopping semaglutide at least 2 months before a planned pregnancy because of its roughly one-week half-life. This is a label instruction, not personal medical advice; confirm timing with your clinician.
Does Wegovy affect birth control pills?: The semaglutide label, unlike tirzepatide, does not warn that it reduces oral-contraceptive effectiveness. However, weight loss itself can restore ovulation, so reliable contraception still matters.
Can Wegovy be used for PCOS-related weight?: It is not FDA-approved for PCOS. The 2023 International PCOS Guideline lists anti-obesity medications as an adjunct option when weight management is a treatment goal, so any PCOS use is off-label and clinician-directed.

Sources

Every claim above resolves to an FDA label, published trial, guideline, or manufacturer / GoodRx pricing page. External links open in a new tab.

For the general (non women-specific) mechanism, dosing, and side-effect incidence, see our semaglutide medication overview.

Compare other options

Zepbound for women — GIP/GLP-1 receptor dual agonist (tirzepatide)
Ozempic for women — GLP-1 receptor agonist (semaglutide)
Compounded semaglutide for women — Compounded GLP-1 receptor agonist (semaglutide)
Back to the GLP-1 for women guide

ClearHormones updates this explainer as FDA status and pricing change. Verify current approval status and pricing on the manufacturer or FDA page before acting.